Comparison between Capillary Technologies IPO and Sudeep Pharma IPO.
Capillary Technologies IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Sudeep Pharma IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Capillary Technologies IPO is up to ₹877.50 Cr whereas the issue size of the Sudeep Pharma IPO is up to ₹895.00 Cr. The final issue price of Capillary Technologies IPO is ₹577.00 per share and of Sudeep Pharma IPO is ₹593.00 per share.
| Capillary Technologies IPO | Sudeep Pharma IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹1 per share |
| Issue Price (Lower) | ₹549.00 per share | ₹563.00 per share |
| Issue Price (Upper) | ₹577.00 per share | ₹593.00 per share |
| Issue Price (Final) | ₹577.00 per share | ₹593.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ₹52.00 per share | |
| Market Lot Size | 25 shares | 25 shares |
| Fresh Issue Size | 59,82,635 shares | 16,02,023 shares |
| Fresh Issue Size (Amount) | up to ₹345.12 Cr | up to ₹95.00 Cr |
| OFS Issue Size | 92,28,796 shares | 1,34,90,726 shares |
| OFS Issue Size (Amount) | up to ₹532.38 Cr | up to ₹800.00 Cr |
| Issue Size Total | 1,52,11,431 shares | 1,50,92,749 shares |
| Issue Size Total (Amount) | up to ₹877.50 Cr | up to ₹895.00 Cr |
Capillary Technologies IPO opens on Nov 14, 2025, while Sudeep Pharma IPO opens on Nov 21, 2025. The closing date of Capillary Technologies IPO and Sudeep Pharma IPO is Nov 18, 2025, and Nov 25, 2025, respectively.
| Capillary Technologies IPO | Sudeep Pharma IPO | |
|---|---|---|
| Anchor Bid Date | Nov 13, 2025 | Nov 20, 2025 |
| Issue Open | Nov 14, 2025 | Nov 21, 2025 |
| Issue Close | Nov 18, 2025 | Nov 25, 2025 |
| Basis Of Allotment (Tentative) | Nov 19, 2025 | Nov 26, 2025 |
| Initiation of Refunds (Tentative) | Nov 20, 2025 | Nov 27, 2025 |
| Credit of Share (Tentative) | Nov 20, 2025 | Nov 27, 2025 |
| Listing date (Tentative) | Nov 21, 2025 | Nov 28, 2025 |
| Anchor Lockin End date 1 | Dec 18, 2025 | Dec 26, 2025 |
| Anchor Lockin End date 2 | Feb 16, 2026 | Feb 24, 2026 |
Capillary Technologies IPO P/E ratio is 298.93, as compared to Sudeep Pharma IPO P/E ratio of 47.61.
| Capillary Technologies IPO | Sudeep Pharma IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)Capillary Technologies India Ltd.'s revenue increased by 14% and profit after tax (PAT) rose by 121% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)Sudeep Pharma Ltd.'s revenue increased by 10% and profit after tax (PAT) rose by 4% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 67.95 | 89.37 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 52.05 | 76.15 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 298.93 | 47.61 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹4576.09 Cr. | ₹6697.85 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 2.76% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.18 | 0.20 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹1.93 | ₹12.46 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 2.85% | 27.88% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Capillary Technologies IPO Retail Individual Investors (RII) are offered 15,17,333 shares while in Sudeep Pharma IPO retail investors are offered 15,17,333 shares. Qualified Institutional Buyers (QIB) are offered 45,52,002 shares in Capillary Technologies IPO and 30,18,550 shares in Sudeep Pharma IPO.
| Capillary Technologies IPO | Sudeep Pharma IPO | |
|---|---|---|
| Anchor Investor Reservation | 68,28,001 shares | 45,27,823 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 45,52,002 shares | 30,18,550 shares |
| NII | 22,76,000 shares | 22,63,913 shares |
| RII | 15,17,333 shares | 52,82,463 shares |
| Employee | 38,095 shares | 0 shares |
| Others | ||
| Total | 1,52,11,431 shares | 1,50,92,749 shares |
Capillary Technologies IPO subscribed 52.98x in total, whereas Sudeep Pharma IPO subscribed 93.71x.
| Capillary Technologies IPO | Sudeep Pharma IPO | |
|---|---|---|
| QIB (times) | 57.30x | 213.08x |
| NII (times) | 69.85x | 116.72x |
| Big NII (times) | 85.42x | 134.91x |
| Small NII (times) | 38.72x | 80.33x |
| RII (times) | 15.85x | 15.65x |
| Employee (times) | 6.88x | |
| Other (times) | ||
| Total (times) | 52.98x | 93.71x |
